Selective serotonin reuptake inhibitor (SSRI). Prepn: K. P. Boegesoe, A. S. Toft, DE 2657013; eidem, US 4136193 (1977, 1979 both to Kefalas); A. J. Bigler et al., Eur. J. Med. Chem. - Chim. Ther. 12, 289 (1977). Prepn of enantiomers: K. P. Boegesoe, J. Perregaard, EP 347066; eidem, US 4943590, reissued as US RE 34712 (1989, 1990, 1994 all to Lundbeck). Pharmacology: A. V. Christensen et al., Eur. J. Pharmacol. 41, 153 (1977). HPLC determn in plasma and urine: E. Oyehaug et al., J. Chromatogr. 308, 199 (1984). Comparative biotransformation of enantiomers: L. L. Von Moltke et al., Drug Metab. Dispos. 29, 1102 (2001). Evaluation of suicidality risk: G. Laje et al., Am. J. Psychiatry 164, 1530 (2007). Review of clinical pharmacokinetics: K. Brosen, C. A. Naranjo, Eur. Neuropsychopharmacol. 11, 275-283 (2001). Review of clinical experience in depression: M. B. Keller, J. Clin. Psychiatry 61, 896-908 (2000); of escitalopram in depression: P. Malin et al., Expert Rev. Neurother. 4, 769-779 (2004); in anxiety disorders: D. S. Baldwin, R. V. Nair, ibid. 5, 443-449 (2005); S. R. Bareggi et al., Expert Opin. Drug Metab. Toxicol. 3, 741-753 (2007).
Antidepressant. Escitalopram as antidepressant, anxiolytic.
Antidepressant; Bicyclics; Serotonin Uptake Inhibitor
Escitalopram: Antidepressant; Bicyclics; Anxiolytic; Serotonin Uptake Inhibitor